ROSA ANCAYA: Open Payments
NPI 1417541202 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 9 payments from 9 companies in 2025. Trend: 2023 $89 · 2024 $561 · 2025 $799
Food & beverage: $749Education: $50
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 1 | $149 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Kite Pharma, Inc. | 1 | $121 |
| JAZZ PHARMACEUTICALS INC. | 1 | $120 |
| Amgen Inc. | 1 | $54 |
| SEAGEN INC. | 1 | $50 |
| Celgene Corporation | 1 | $30 |
| Regeneron Pharmaceuticals, Inc. | 1 | $25 |
Products named: ZYNLONTA, ICLUSIG, Yescarta, RYLAZE, BLINCYTO, BREYANZI, LYNOZYFIC.
Industry payments across FL — which companies pay providers there.
